文献速递免疫规划

PnuBioVax多抗原非血清型依赖性肺炎链球菌预防性疫苗的免疫原性及作用机制

Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with Streptococcus pneumoniae.
PubMed 文献 · Vaccine · 2018-06-09

本研究旨在阐明PnuBioVax(PBV)多抗原非血清型依赖性肺炎链球菌疫苗在免疫家兔中的免疫应答。与对照血清相比,PBV免疫家兔血清含高水平的针对PBV疫苗及肺炎链球菌抗原PspA、Ply、PsaA和PiuA的IgG抗体。PBV血清在调理吞噬杀伤试验中支持杀伤疫苗株TIGR4及异源株6B、19F和15B,并导致肺炎链球菌凝集、抑制Ply介导的红细胞裂解及体外减少细菌侵袭肺上皮细胞。

要点

  • PBV免疫家兔血清含高水平抗PBV及PspA、Ply、PsaA、PiuA的IgG抗体。
  • PBV血清支持调理吞噬杀伤疫苗株TIGR4及异源株6B、19F、15B。
  • PBV血清可凝集肺炎链球菌、抑制Ply介导溶血并减少体外肺上皮细胞侵袭。

核心结论

  • PBV疫苗接种产生的血清具有多种作用机制,可能提供有效的抗肺炎链球菌感染保护,并比当前多糖疫苗覆盖更广的菌株。

研究设计与样本

  • 本研究为动物实验,旨在阐明PBV在免疫家兔中的免疫应答。

主要发现

  • 与对照血清相比,PBV免疫家兔血清含高水平针对PBV疫苗及肺炎链球菌抗原PspA、Ply、PsaA和PiuA的IgG抗体。

关键数值与推荐

  • PBV血清在调理吞噬杀伤试验中支持杀伤疫苗株TIGR4及异源株6B、19F和15B。
  • PBV血清孵育导致多株肺炎链球菌凝集,抑制Ply介导的红细胞裂解,并减少体外细菌侵袭肺上皮细胞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Streptococcus pneumoniae has multiple protein antigens on the surface in addition to the serotype specific polysaccharide capsule antigen. Whilst the capsule antigen is the target of the polysaccharide vaccines, bacterial proteins can also act as targets for the immune system. PnuBioVax (PBV) is being developed as a multi-antigen, serotype-independent prophylactic vaccine against S. pneumoniae disease. In this study we have sought to elucidate the immune response to PBV in immunised rabbits. Sera from PBV immunised rabbits contained high levels of IgG antibodies to the PBV vaccine, and pneumococcal antigens PspA, Ply, PsaA and PiuA which are components of PBV, when compared with control sera. The PBV sera supported killing of the vaccine strain TIGR4 in an opsonophagocytic killing assay and heterologous strains 6B, 19F and 15B. In addition, incubation in PBV sera led to agglutination of several strains of pneumococci, inhibition of Ply-mediated lysis of erythrocytes and reduced bacterial invasion of lung epithelial cells in vitro. These data suggest that PBV vaccination generates sera that has multiple mechanisms of action that may provide effective protection against pneumococcal infection and give broader strain coverage than the current polysaccharide based vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hill S, Entwisle C, Pang Y, et al. Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with Streptococcus pneumoniae. Vaccine. 2018. PMID: 29895498. doi:10.1016/j.vaccine.2018.05.122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。